Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Status PubMed-not-MEDLINE Language English Country England, Great Britain Media electronic
Document type Published Erratum
PubMed
35086550
PubMed Central
PMC8793270
DOI
10.1186/s13046-022-02247-y
PII: 10.1186/s13046-022-02247-y
Knihovny.cz E-resources
- Publication type
- Published Erratum MeSH
Core Facilities Bambino Gesu Children's Hospital IRCCS Rome Italy
Department of Life Health and Environmental Sciences MESVA University of L'Aquila L'Aquila Italy
Experimental Imaging Center IRCCS San Raffaele Scientific Institute 20132 Milan Italy
Francesco Balsano Foundation Rome Italy
Genetics and Rare Diseases Research Division Bambino Gesu Children's Hospital IRCCS Rome Italy
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Unit of Oncogenomic and Epigenetic IRCCS Regina Elena National Cancer Institute Rome Italy